Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jul;12(3):162-6.
doi: 10.4103/0972-2327.56315.

Assessment of total sialic acid and lipid-bound sialic acid in management of brain tumors

Manjula Shantaram  1 , Anjali Rao, Annaya Rao Aroor, Annaswamy Raja, Suryanrayana Rao, Flama Monteiro
Affiliations

Assessment of total sialic acid and lipid-bound sialic acid in management of brain tumors

Manjula Shantaram et al. Ann Indian Acad Neurol. 2009 Jul.

Abstract

Background: Glycoconjugate molecules expressed at the plasma membrane of mammalian cells have been reported to be associated with tumor progression. The measurement of total sialic acid (TSA) and lipid-bound sialic acid (LBSA) in the cerebrospinal fluid (CSF) is suggested to be useful for the diagnosis of brain tumors. But there are very few reports available on the serum glycoconjugate levels in patients with brain tumors.

Objective: The objective of this study is to check the feasibility of using serum glycoconjugates such as TSA and LBSA as tumor markers in brain tumor patients.

Materials and methods: Colorimetric estimation of TSA using diphenylamine was done on 100 patients with intracranial tumors; follow-up study was carried out in 24 cases. The LBSA fraction was isolated from the serum of 68 brain tumor patients and evaluated using phosphotungstic acid and resorcinol; follow-up study was done on 23 patients. The various types of brain tumors included in this study were glioma, meningioma, and acoustic neurinoma as well as some other types such as medulloblastoma, secondary tumors, and craniopharyngioma.

Results: There was no significant difference between the TSA and LBSA concentrations seen in pretreatment or post-treatment cases and that seen in control subjects.

Discussion: TSA and LBSA do not have the ability to discriminate between benign and malignant brain tumors. TSA and LBSA appear to be tumor markers of very limited value in patients with brain tumors.

Keywords: Brain tumors; lipid-bound sialic acid; total sialic acid; tumor markers.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Nil

Figures

Figure 1
Figure 1
Total sialic acid in preoperative and post-treatment cases (mean)
Figure 2
Figure 2
Lipid-bound sialic acid in preoperative and post-treatment cases (mean)
See this image and copyright information in PMC

References

    1. Warren L, Buck CA. The membrane glycoproteins of the malignant cell. Clin Biochem. 1980;13:191–971. - PubMed
    1. Mali HR, Bhatt ML, Gupta JP, Singh MP. Serum sialic acid level: Possible role as a biomarker in head and neck cancer during radiotherapy. J Clin Radiother Oncol. 1995;10:44–6.
    1. Zing RD, Chen RM, Wang ZS, Zhang YZ. Serum sialic acid levels in patients with oral and maxillofacial malignancy. J Oral Maxillofac Surg. 1991;49:843–7. - PubMed
    1. Aranganathan S, Senthil K, Nalini N. A case control study of glycoprotein status in ovarian carcinoma. Clin Biochem. 2005;38:535–9. - PubMed
    1. Gokmen SS, Kazezoglu C, Tabakoglu E, Altiay G, Gungor O, Ture M. Serum total sialic acid levels in lung cancer patients of different histological types with and no extrapulmonary metastases. Turkish J Biochem. 2004;29:262–7.